Helius Medical Technologies, Inc.
HSDT
$6.21
-$0.06-0.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -156.20% | 2.29% | -6.57% | -128.66% | 35.93% |
| Total Depreciation and Amortization | 8,512.50% | -33.33% | -25.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,217.75% | -62.52% | 22.18% | 186.23% | -162.55% |
| Change in Net Operating Assets | 140.54% | -171.15% | 276.87% | -79.27% | -110.26% |
| Cash from Operations | 22.03% | -48.70% | 14.18% | 4.15% | 3.67% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 48.90% | -- | -100.00% | -99.94% | 3.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,180.24% | -- | 100.00% | -103.70% | 5,650.68% |
| Cash from Financing | 117.21% | -- | 100.00% | -102.64% | 285.51% |
| Foreign Exchange rate Adjustments | -- | -- | -300.00% | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23,561.90% | 100.88% | 18.47% | -206.18% | 278.04% |